Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Stübiger

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 10, 2017
Therapy Rationale for Mineralocorticoid-Receptor Antagonists, Acetazolamide and a Switch of Therapy in Nonresponders in Central Serous ChorioretinopathyAnne Rübsam, Claudia E Thieme, Juliane Schlomberg, et al.
Plos One|May 27, 2015
Subretinal fluid in eyes with active ocular toxoplasmosis observed using spectral domain optical coherence tomographyYanling Ouyang, Fuqiang Li, Qing Shao, et al.
Plos One|February 8, 2014
Evaluation of cystoid change phenotypes in ocular toxoplasmosis using optical coherence tomographyYanling Ouyang, Uwe Pleyer, Qing Shao, et al.
Seminars in Arthritis and Rheumatism|April 14, 2004
Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trialIna Kötter, Reinhard Vonthein, Manfred Zierhut, et al.
Neuro-Signals|May 4, 2021
Primary Vitreoretinal Lymphoma Therapy Monitoring: Significant Vitreous Haze Reduction After Intravitreal RituximabVinodh Kakkassery, Ludwig M Heindl, Alexander C Rokohl, et al.
Zeitschrift Fur Rheumatologie|August 4, 2022
[Sarcoidosis as prime example of a granulomatous disease]Tim Oqueka, Sören Galow, Marcel Simon, et al.
Klinische Monatsblatter Fur Augenheilkunde|May 24, 2022
On the Current Care Situation and Treatment of Ocular Mucous Membrane Pemphigoid in GermanyRémi Yaïci, Mathias Roth, Lukas Juergens, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 10, 2017
Therapy Rationale for Mineralocorticoid-Receptor Antagonists, Acetazolamide and a Switch of Therapy in Nonresponders in Central Serous ChorioretinopathyAnne Rübsam, Claudia E Thieme, Juliane Schlomberg, et al.
Plos One|May 27, 2015
Subretinal fluid in eyes with active ocular toxoplasmosis observed using spectral domain optical coherence tomographyYanling Ouyang, Fuqiang Li, Qing Shao, et al.
Plos One|February 8, 2014
Evaluation of cystoid change phenotypes in ocular toxoplasmosis using optical coherence tomographyYanling Ouyang, Uwe Pleyer, Qing Shao, et al.
Seminars in Arthritis and Rheumatism|April 14, 2004
Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trialIna Kötter, Reinhard Vonthein, Manfred Zierhut, et al.
Neuro-Signals|May 4, 2021
Primary Vitreoretinal Lymphoma Therapy Monitoring: Significant Vitreous Haze Reduction After Intravitreal RituximabVinodh Kakkassery, Ludwig M Heindl, Alexander C Rokohl, et al.
Zeitschrift Fur Rheumatologie|August 4, 2022
[Sarcoidosis as prime example of a granulomatous disease]Tim Oqueka, Sören Galow, Marcel Simon, et al.
Klinische Monatsblatter Fur Augenheilkunde|May 24, 2022
On the Current Care Situation and Treatment of Ocular Mucous Membrane Pemphigoid in GermanyRémi Yaïci, Mathias Roth, Lukas Juergens, et al.
Pageof 3